BioDirection Inc.

Point-of-care blood test for traumatic brain injury

BioDirection Inc. is poised to launch what it says is the first objective point-of-care test for diagnosing concussion and other traumatic brain injuries. Based on proprietary nanotechnology, the company’s Tbit device detects molecular levels of two crucial brain biomarkers that are released into the bloodstream immediately after a brain injury, from just a single drop of blood in less than two minutes.

More from Archive

More from Medtech Insight

UK NHS Must Capture Data For Next Generation Of AI In Healthcare

 

While the UK’s new plan to unlock public health data is a good start, complete, accessible data and regional computational infrastructure are needed to properly train AI for healthcare innovation, AI expert Muhammad Bilal tells Medtech Insight.

EU Launches First Specific Plan On Cybersecurity For Healthcare Providers

 

Member states reported 309 significant cybersecurity incidents affecting the healthcare sector in 2023 – more than in any other critical sector.

Industry Says EMA’s Strict New Conflict Of Interest Rules Could Limit Access To Experts

 

The European Medicines Agency has published new policies on handling conflicts of interests for its scientific committee members, experts and management board members.